CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study

Mise à jour : Il y a 5 ans
Référence : NCT01719835

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This is a randomised, open-label phase II study comparing GEM-P chemotherapy (experimental arm) with CHOP (control arm) in previously untreated T-cell lymphoma. Eligible patients will be randomised 1:1 between 4-weekly GEM-P or 3-weekly CHOP chemotherapy.


Critère d'inclusion

  • Peripheral T-cell Lymphoma NOS,Anaplastic large cell lymphoma, ALK-negative,Angioimmunoblastic T-cell Lymphoma,Hepatosplenic Gamma/ Delta T-cell Lymphoma

Liens